Test helps doctors decide on cancer treatment

22 June 2019 | Research

A research team from Duke-NUS Medical School and the National University Cancer Institute of NUHS, who come under the Singapore Gastric Cancer Consortium has found a way to identify which gastric cancer sufferers would not benefit from immunotherapy, an effort that will save the patients time and money, and spare them possible side effects of such treatments. Conducted in collaboration with South Korea, the team is now planning a large-scale trial involving local and international stomach cancer patients.